Catherine C. Turkel Lexaria Bioscience Corp. (LEXX) insider trading activity
Catherine C. Turkel is Director of Lexaria Bioscience Corp.. Currently has a direct ownership of 1,500 shares of LEXX, which is worth approximately $4,170. The most recent transaction as insider was on Feb 09, 2023, when has been sold 1,500 shares (Common Shares) at a price of $2.84 per share, resulting in proceeds of $4,260. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
1.5K
0%
3M change
0%
12M change
Total Value Held
$4,170
CCT
Catherine C. Turkel
Director
Irvine, CA